Use of ¹⁹F-nuclear magnetic resonance and gas chromatography-electron capture detection in the quantitative analysis of fluorine-containing metabolites in urine of sevoflurane-anaesthetized patients

Reference

• ANSELME, J. P., 1963, A convenient synthesis of phenyldiazomethane. Journal of Organic Chemistry, 28, 592–593.
   Web of Science ®Google Scholar
• BAXTER, P. J., GARTON, K. and KHARASCH, E. D., 1998, Mechanistic aspects of carbon monoxide formation from volatile anesthetics. Anesthesiology, 89, 929–941.
   PubMed Web of Science ®Google Scholar
• BITO, H. and IKEDA, K., 1994, Long duration, low-flow sevoflurane anaesthesia using two carbon dioxide absorbents. Quantification of degradation products in the circuit. Anesthesiology, 81, 340–345.
   PubMed Web of Science ®Google Scholar
• COHEN, E. N., TRUDELL, J. R., EDMUNDS, H. N. and WATSON, E., 1975, Urinary metabolites of halothane in man. Anesthesiology, 43, 392–401.
   PubMed Web of Science ®Google Scholar
• FIESER, L. F. and FIESER, M., 1967, Reagents for Organic Synthesis (New York: Wiley).
   Google Scholar
• FISCHER, B., NUDELMAN, A., RUSE, M., HERZIG, J., GOTTLIEB, H. E. and KEINAN, E., 1984, A novel method for stereoselective glucuronidation. Journal of Organic Chemistry, 49, 4988–4993.
   Web of Science ®Google Scholar
• FRINK, E. J., JR, ISNER, R. J., MALAN, T. P., JR, MORGAN, S. E., BROWN, E. A. and BROWN, B. R., 1994, Sevofiurane degradation product concentrations with soda lime during prolonged anaesthesia. Journal of Clinical Anaesthesia, 6, 239–242.
   Google Scholar
• FRINK, E. J., JR, MALAN, T. P., MORGAN, S. E., BROWN, E. A., MALCOMSON, M. and BROWN, B. R., 1992, Quantification of the degradation products of sevoflurane in two CO2 absorbents during low-flow anaesthesia in surgical patients. Anesthesiology, 77, 1064–1069.
   Google Scholar
• HARRIS, J. W. and ANDERS, M. W., 1991, Metabolism of the hydrochlorofiuorocarbon 1,2-dichloro-1,1-difiuoroethane. Chemical Research in Toxicology, 4, 180–186.
   PubMed Web of Science ®Google Scholar
• HINSBERG, 0., 1890, Ueber die bildung von saureestern und saureamiden bei gegenwart von wasser und alkali. Berichte Devt Chemische Ges, 23, 2962–2965.
   Google Scholar
• HOLADAY, D. A. and SMITH, F. R., 1981, Clinical characteristics and biotransformation of sevoflurane in healthy human volunteers. Anesthesiology, 54, 100–106.
   PubMed Web of Science ®Google Scholar
• IYER, R. A. and ANDERS, M. W., 1996, Cysteine conjugate 13-lyase dependent biotransformation of the cysteine S-conjugates of the sevoflurane degradation product compound A in human, nonhuman primate, and rat kidney cytosol and mitochondria. Anesthesiology, 85, 1454–1461.
   PubMed Web of Science ®Google Scholar
• IYER, R. A. and ANDERS, M. W., 1997, Cysteine conjugate 13-lyase dependent biotransformation of the cysteine S-conjugates of the sevoflurane degradation product 2-(fluoromethoxy)-1,1,3,3,3-pentafluoro-1-propene (compound A). Chemical Research in Toxicology, 10, 811–819.
   PubMed Web of Science ®Google Scholar
• IYER, R. A., FRINK, E. J., EBERT, T. J. and ANDERS, M. W., 1998, Cysteine conjugate 13-lyase dependent metabolism of compound A (2-[fluoromethoxy]-1,1,3,3,3-pentafluoro-1-propene) in human subjects anaesthetised with sevoflurane and in rats given compound A. Anesthesiology, 88, 611–618.
   PubMed Web of Science ®Google Scholar
• JIAXIANG, N., SATO, N., Fuji', K. and YUGE, 0., 1993, Urinary excretion of hexafluoroisopropanol glucuronide and fluoride in patients after sevoflurane anaesthesia. Journal of Pharmacy and Pharmacology, 45, 67–69.
   Google Scholar
• JIN, L., BAILLIE, T., DAVIS, M. R. and KHARASCH, E. D., 1995, Nephrotoxicity of sevoflurane compound A [fluoromethy1-2,2-difluoro-1-(trifluoromethyl)vinyl ether] in rats. Biochemical and Biophysical Research Communication, 210, 498–506.
   PubMed Web of Science ®Google Scholar
• JIN, L., DAVIS, M. R., KHARASCH, E. D., Doss, G. A. and BAILLIE, T. A., 1996, Identification in rat bile of glutathione conjugates of fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether, a nephrotoxic degradate of the anesthetic agent sevoflurane. Chemical Research in Toxicology, 9, 555–561.
   PubMed Web of Science ®Google Scholar
• KHARASCH, E. D., ARMSTRONG, A. S., GUNN, K., ARTRU, A., Cox, K., KAROL, M. D. and LANNI, C., 1995a, Clinical sevoflurane metabolism and disposition II. The role of cytochrome P450 2E1 in fluoride and hexafluoroisopropanol formation. Anesthesiology, 82, 1379–1388.
   PubMed Web of Science ®Google Scholar
• KHARASCH, E. D. and JUBERT, C., 1999b, Compound A uptake and metabolism to mercapturic acids and 3,3,3-trifluoro-2-fluoromethoxypropanoic acid during low flow sevoflurane anaesthesia. Anesthesiology, 91, 1267–1278.
   PubMed Web of Science ®Google Scholar
• KHARASCH, E. D., JUBERT, C., SPRACKLIN, D. K. and HOFFMAN, G. M., 1999a, Dose dependent metabolism of fluoromethy1-2,2-difluoro-1-(trifluoromethyl)vinyl Ether (Compound A), an anesthetic degradation product, to mercapturic acid and 3,3,3-trifluoro-2-(fluoromethoxy) propanoic acid in rats. Toxicology and Applied Pharmacology, 160, 49–59.
   PubMed Web of Science ®Google Scholar
• KHARASCH, E. D., KAROL, M. D., LANNI, C. and SAWCHUK, R., 1995b, Clinical sevoflurane metabolism and disposition I. Sevoflurane and metabolic pharmacokinetics. Anesthesiology, 82, 1369–1378.
   PubMed Web of Science ®Google Scholar
• KIKUCHI, H., MORIO, M., FUJII, K., MUKAIDA, K., HORIBE, M., DAVIDKOVA, T. I., KAWACHI, S. and SATO, N., 1987, Clinical evaluation and metabolism of sevoflurane in patients. Hiroshima Journal of Medical Sciences, 36, 93–97.
   PubMedGoogle Scholar
• MARTINO, R., MALET-MARTINO, M. and GILARD, V., 2000, Fluorine nuclear magnetic resonance, a privileged tool for metabolic studies of fluoropyrimidine drugs. Current Drug Metabolism, 1, 271–303.
   Google Scholar
• MARTIS, L., LYNCH, S., NAPOLI, M. D. and WooDs, E. F., 1981, Biotransformation of sevoflurane in dogs and rats. Anaesthesia and Analgesia, 60, 186–191.
   PubMed Web of Science ®Google Scholar
• MORGAN, S. E., FRINK, E. J. and GANDOLFI, J., 1994, A simplified gas chromatographic method for quantifying the sevoflurane metabolite hexafluoroisopropanol. Anesthesiology, 80, 201–205.
   PubMed Web of Science ®Google Scholar
• ORHAN, H., VERMEULEN, N. P. E., SAHIN, G. and COMMANDEUR, J. N. M., 2001, Characterisation of thioether compounds formed from potentially nephrotoxic alkaline degradation products of enflurane. Anesthesiology, 95, 165–175.
   Google Scholar
• ROOSEBOOM, M., COMMANDEUR, J. N. M., FLOOR, G. C., RETTIE, A. E. and VERMEULEN, N. P. E., 2001, Selenoxidation by flavin-containing monooxygenases as a novel pathways for 13-elimination of selenocysteine Se-conjugates. Chemical Research in Toxicology, 14, 127–134.
   Google Scholar
• SPRACKLIN, D. and KHARASCH, E. D., 1996, Evidence for the metabolism of fluoromethy1-2,2-difluoro-1-(trifluoromethyl)vinyl ether (compound A) by cysteine conjugate 13-lyase in rats. Chemical Research in Toxicology, 9, 696–702.
   PubMed Web of Science ®Google Scholar
• UTTAMSINGH, V., IYER, R. A., BAGGS, R. B. and ANDERS, M. W., 1998, Fate and toxicity of 2-(fluoromethoxy)-1,1,3,3,3-pentafluoro-1-propene (compound A)-derived mercapturates in male, Fischer 344 rats. Anesthesiology, 89, 1174–1183.
   PubMed Web of Science ®Google Scholar
• VAN WELIE, R. T. H., VAN DICK, R. G. J. M., VERMEULEN, N. P. E. and VAN SITTERT, N. J., 1992, Mercapturic acids and protein and DNA adducts as biomarkers of electrophilic chemicals. Critical Reviews in Toxicology, 22, 271–306.
   Google Scholar
• WARK, H., EARL, J., OVERTON, J. and CHEUNG, H. T. A., 1990, A urinary cysteine-halothane metabolite: Validation and measurement in children. British Journal of Anaesthesia, 64, 469–473.
   PubMed Web of Science ®Google Scholar